Medical imaging, robotics, and AI technology company Promaxo, Inc. (Promaxo) announced today the appointment of Theresa A. Matacia, CFA as Chief Financial Officer. With a mission to improve lives through state-of-the-art medical technology, Promaxo has made marked progress over the last year, recently receiving the 510(k) clearance from the FDA for its Innovational MRI Platform.
“Theresa’s extensive experience and proven track record leading corporate financial strategies is a significant value add to Promaxo’s development, as we strive to continue to expand our presence in the market,” said Dr. Amit Vohra, Founder, and CEO of Promaxo. “As an accomplished financial expert, particularly in B2B, Theresa will play an integral role in developing and implementing initiatives that will drive the Company’s growth.”
Matacia’s record in business and Wall Street includes execution of transactions of around $3B in value. Formerly with ADP, Scient, Inc, and ADESA, Matacia will support the company’s vision and goals of creating a technological solution that will better patient lives and physicians’ abilities to treat cancers.
“As a Chief Financial Officer, my passion has always been to elevate the potential of companies through strategic financial planning,” said Matacia. “My early career on Wall Street provided me the chance to become well-versed in the technology software and services industries, and I’m thrilled to be expanding this knowledge to the medical technology industry. I’m looking forward to working with the Promaxo team to grow the business and raise our profile in the medtech ecosystem.”
Recently, Promaxo raised a funding round led by Zepp Health. Promaxo is poised to improve the patient experience and enhance the in-office care continuum for physicians..
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.